{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:08:49Z","timestamp":1754161729997,"version":"3.41.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173115, 82303865"],"award-info":[{"award-number":["82173115, 82303865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Backgrounds<\/jats:title><jats:p>Triple-negative breast cancer (TNBC) represents the most aggressive breast cancer subtype. The limited treatment options underscore the urgent need to explore novel molecular targets to combat TNBC progression. This study investigates the oncogenic functions of SHCBP1 in TNBC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Bulk RNA-seq and single-cell sequencing (scRNA-seq) data for TNBC samples were acquired from the Cancer Genome Atlas (TCGA) dataset and GSE161529, respectively. SHCBP1 expression at the mRNA and protein levels was compared between TNBC and normal breast tissues. The prognostic significance of SHCBP1 in TNBC was assessed using Kaplan\u2013Meier analysis. The potential biological functions of SHCBP1 were explored through gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and gene set enrichment analysis (GSEA). Immunofluorescence was utilized to determine the subcellular localization of SHCBP1 during cell division. Quantitative PCR (qPCR) and western blotting were employed to measure SHCBP1 expression in breast cancer cell lines. Subsequently, the impact of SHCBP1 on TNBC cell proliferation and migration was evaluated <jats:italic>in vitro<\/jats:italic>. Finally, scRNA-seq analysis was conducted to characterize SHCBP1 expression patterns at the single-cell resolution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>SHCBP1 is markedly upregulated in TNBC tissues, and its overexpression is associated with poorer survival outcomes. Functional enrichment analysis reveals that SHCBP1-related genes are significantly enriched in pathways involved in cell-cycle regulation and DNA damage response. <jats:italic>In vitro<\/jats:italic> studies demonstrate that SHCBP1 enhances TNBC cell proliferation and migration. The scRNA-seq analysis displays the cell clusters in which SHCBP1 is primarily expressed. Cancer epithelial cells exhibiting higher SHCBP1 expression display stronger interactions with stromal cells in the tumor microenvironment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study elucidates the critical role of SHCBP1 in TNBC progression, highlighting its potential as a therapeutic target. These findings provide a foundation for further exploration of SHCBP1 in TNBC treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1587236","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T08:02:09Z","timestamp":1753776129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["SHCBP1 drives tumor progression in triple-negative breast cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Huiling","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e071674","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1177","article-title":"Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment","volume":"9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discovery"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature12308","article-title":"Temporal regulation of EGF signalling networks by the scaffold protein Shc1","volume":"499","author":"Zheng","year":"2013","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13058-019-1155-7","article-title":"The p52 isoform of SHC1 is a key driver of breast cancer initiation","volume":"21","author":"Wright","year":"2019","journal-title":"Breast Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/1568009619666190620114928","article-title":"The role of shcbp1 in signaling and disease","volume":"19","author":"Zhang","year":"2019","journal-title":"Curr Cancer Drug Targets"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41419-021-04479-w","article-title":"EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation","volume":"13","author":"Yin","year":"2022","journal-title":"Cell Death Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1038\/s41467-021-23053-8","article-title":"Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer","volume":"12","author":"Shi","year":"2021","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"116798","DOI":"10.1016\/j.lfs.2019.116798","article-title":"SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway","volume":"235","author":"Zou","year":"2019","journal-title":"Life Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7150\/jca.88072","article-title":"SHCBP1 promotes the proliferation of breast cancer cells by inhibiting CXCL2","volume":"14","author":"Yu","year":"2023","journal-title":"J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2016.04.046","article-title":"SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human Malignant breast cancer cell line","volume":"587","author":"Feng","year":"2016","journal-title":"Gene"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.124875","article-title":"The Aurora-B-mediated phosphorylation of SHCBP1 regulates cytokinetic furrow ingression","volume":"126","author":"Asano","year":"2013","journal-title":"J Cell Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4161\/15384101.2015.945840","article-title":"SHCBP1 is required for midbody organization and cytokinesis completion","volume":"13","author":"Asano","year":"2014","journal-title":"Cell Cycle"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2022.06.039","article-title":"Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers","volume":"20","author":"Wang","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0473-z","article-title":"EGF-induced nuclear localization of SHCBP1 activates \u03b2-catenin signaling and promotes cancer progression","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10520","article-title":"SHCBP1 regulates apoptosis in lung cancer cells through phosphatase and tensin homolog","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2021.01.010","article-title":"SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer","volume":"113","author":"Yang","year":"2021","journal-title":"Genomics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03247-1","article-title":"SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis","volume":"146","author":"Xu","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1767056","DOI":"10.1155\/2020\/1767056","article-title":"PART1 and hsa-miR-429-mediated SHCBP1 expression is an independent predictor of poor prognosis in glioma patients","volume":"2020","author":"Xuan","year":"2020","journal-title":"BioMed Res Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22834","article-title":"Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-\u03baB signaling pathway","volume":"57","author":"Zhou","year":"2018","journal-title":"Mol Carcinog"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2020.1824512","article-title":"FGF13 interaction with SHCBP1 activates AKT-GSK3\u03b1\/\u03b2 signaling and promotes the proliferation of A549 cells","volume":"21","author":"Lu","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/hed.26961","article-title":"Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma","volume":"44","author":"Sun","year":"2022","journal-title":"Head Neck"},{"key":"B22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12964-024-01513-0","article-title":"The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy","volume":"22","author":"Zhou","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","article-title":"Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma","volume":"170","author":"Qin","year":"2017","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-018-0628-y","article-title":"Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer","volume":"11","author":"Huang","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1476-4598-10-102","article-title":"Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma","volume":"10","author":"Obchoei","year":"2011","journal-title":"Mol Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-0912","article-title":"A GRN autocrine-dependent FAM135B\/AKT\/mTOR feedforward loop promotes esophageal squamous cell carcinoma progression","volume":"81","author":"Dong","year":"2021","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605490","article-title":"Epidermal growth factor signalling and bone metastasis","volume":"102","author":"Lu","year":"2010","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111424","article-title":"Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth","volume":"209","author":"Hamerlik","year":"2012","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e104063","DOI":"10.15252\/embj.2019104063","article-title":"Stromal cell diversity associated with immune evasion in human triple-negative breast cancer","volume":"39","author":"Wu","year":"2020","journal-title":"EMBO J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: a cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B36","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1587236\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T08:02:09Z","timestamp":1753776129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1587236\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":38,"alternative-id":["10.3389\/fonc.2025.1587236"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1587236","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"article-number":"1587236"}}